News | July 23, 2025
Akums launches high-strength Paracetamol oral suspension 500mg/5ml
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
All the capex is being met through internal accruals only
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
The company highlighted continued demand strength and pricing resilience despite global disruptions
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
